小细胞肺癌患者外周血中Th9细胞水平检测及其临床意义

doi:10.13481/j.1671-587x.20160327

摘要/Abstract

摘要：

目的: 检测小细胞肺癌(SCLC)患者血清中白细胞介素9(IL-9)的水平和外周血中Th9的细胞比例,探讨Th9在SCLC疾病进展过程中的作用。方法: 选择20例局限期SCLC患者(局限期SCLC组)、16例扩散期SCLC患者(扩散期SCLC组)和10名健康对照者(健康对照组)。ELISA法检测各组研究对象血清中IL-9水平,流式细胞术检测各组研究对象外周血Th9细胞在CD4⁺T细胞中所占比例。结果: SCLC组患者外周血中Th9细胞比例高于健康对照组(t=3.731,P<0.01),局限期SCLC患者外周血中Th9细胞比例低于扩散期SCLC组(t=2.825,P<0.01)。SCLC组患者血清IL-9水平高于健康对照组(t=4.001,P<0.01),局限期SCLC组患者血清中IL-9水平低于扩散期SCLC组(t=3.089,P<0.01);结论: Th9可能通过分泌IL-9直接促进SCLC的疾病进展,外周血中Th9细胞和IL-9可能成为评价小细胞肺癌的分子标志。

关键词: 癌, 小细胞肺, Th9细胞, 白细胞介素9, 临床分期, 肿瘤进展

Abstract:

Objective: To detect the ratios of peripheral blood Th9 cells and the levels of serum IL-9 in the patients with small cell lung cancer (SCLC),and to investigate the effect of Th9 cells on the development of human SCLC. Methods: Twenty SCLC patients at limited stage(limited stage SCLC group),16 SCLC patients at extensive stage(extensive stage SCLC group), and 10 healthy controls (healthy control group) were selected.The ratios of Th9 cells to CD4⁺ cells in peripheral blood and the levels of serum IL-9 were detected by flow cytometry and ELISA, respectively. Results: Compared with healthy control group,the level of serum IL-9 of the patients in SCLC group was increased(t=4.001,P<0.01),and the levels of IL-9 of the patients in limited stage SCLC group was lower than that in extensive stage SCLC group(t=3.089,P<0.01).The ratio of Th9 cells of the patients in SCLC group was higher than that in healthy control group (t=3.731,P<0.01),and the ratio of Th9 cells of the patients in limited stage SCLC group was lower than that in extensive stage SCLC group (t=2.825,P<0.01). Conclusion: Th9 might directly promote the development of SCLC through secreting IL-9.The peripheral blood Th9 cells and IL-9 might be biomarkers to evaluate SCLC progression.

Key words: cancer,small cell lung, Th9 cell, interleukin-9, clinical stage, tumor progression

中图分类号:

R734.2

孙牧男, 方艳秋, 刘磊, 马寅芙, 魏海峰, 谭岩. 小细胞肺癌患者外周血中Th9细胞水平检测及其临床意义[J]. 吉林大学学报(医学版), 2016, 42(03): 561-564.

SUN Munan, FANG Yanqiu, LIU Lei, MA Yinfu, WEI Haifeng, TAN Yan. Detection of Th9 cells in peripheral blood of patients with small cell lung cancer and its clinical significance[J]. Journal of Jilin University Medicine Edition, 2016, 42(03): 561-564.

参考文献

[1] Beasley MB,Brambilla E,Travis WD. The 2004 World Health Organization classification of lung tumors [J].Semin Roentgenol,2005,40(2):90-97.

[2] Travis WD,Travis LB,Devesa SS.Lung cancer [J].Cancer,1995,75(1Suppl1):191-202.

[3] Worden FP,Kalemkerian GP.Therapeutic advances in small cell lung cancer [J].Expert Opin Investig Drugs,2000,9(3):565-579.

[4] Socinski MA,Bogart JA.Limited-stage small-cell lung cancer:the current status of combined-modality therapy [J].J Clin Oncol,2007,25(26):4137-4145.

[5] Seow A,Ng DP,Choo S,et al.Joint effect of asthma/atopy and an IL-6 gene polymorphism on lung cancer risk among lifetime non-smoking Chinese women [J].Carcinogenesis,2006,27(6):1240-1244.

[6] Johnson SK,Kerr KM,Chapman AD,et al.Immune cell infiltrates and prognosis in primary carcinoma of the lung [J].Lung Cancer,2000,27(1):27-35.

[7] Hiraoka K,Miyamoto M,Cho Y,et al.Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma [J].Br J Cancer,2006,94(2):275-280.

[8] Munn DH,Bronte V.Immune suppressive mechanisms in the tumor microenvironment [J].Curr Opin Immunol,2016,39:1-6.

[9] Zhu J,Yamane H,Paul WE.Differentiation of effector CD4 T cell populations [J].Ann Rev Immunol,2010,28:445-489.

[10] Cox CA,Shi G,Yin H,et al.Both Th1 and Th17 are immunopathogenic but differ in other key biological activities [J].J Immunol,2008,180(11):7414-7422.

[11] Davidson MG,Alonso MN,Yuan R,et al.Th17 cells induce Th1 polarizing monocyte-derived dendritic cells [J].J Immunol,2013,191(3):1175-1187.

[12] Ye ZJ,Zhou Q,Yin W,et al.Differentiation and immune regulation of IL-9-producing CD4+ T cells in malignant pleural effusion [J].Am J Respir Crit Care Med,2012,186(11):1168-1179.

[13] Nakatsukasa H,Zhang D,Maruyama T,et al.The DNA-binding inhibitor Id3 regulates IL-9 production in CD4(+) T cells [J].Nat Immunol,2015,16(10):1077-1084.

[14] Froidure A,Shen C,Gras D,et al.Myeloid dendritic cells are primed in allergic asthma for thymic stromal lymphopoietin-mediated induction of Th2 and Th9 responses [J].Allergy,2014,69(8):1068-1076.

[15] Chen N,Lu K,Li P,et al.Overexpression of IL-9 induced by STAT6 activation promotes the pathogenesis of chronic lymphocytic leukemia [J].Int J Clin Exp Pathol,2014,7(5):2319-2323.

[16] Niedbala W,Besnard AG,Nascimento DC,et al.Nitric oxide enhances Th9 cell differentiation and airway inflammation [J].Nat Commun,2014,5:4575.

[17] Ma CS,Tangye SG,Deenick EK.Human Th9 cells:inflammatory cytokines modulate IL-9 production through the induction of IL-21 [J].Immunol Cell Biol,2010,88(6):621-623.

[18] Li H,Rostami A.IL-9:basic biology,signaling pathways in CD4+ T cells and implications for autoimmunity [J].J Neuroimmune Pharmacol,2010,5(2):198-209.

[19] Adamson AS,Collins K,Laurence A,et al.The current status of lymphocyte signaling:new roles for old players [J].Curr Opin Immunol,2009,21(2):161-166.